Colby Pharmaceutical Company Report issue

For profit Phase 1 Phase 2
Founded: Wellesley MA United States (1997)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2008
NCT00662272
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (4)

Key: Colby Pharmaceutical Company (1) Acquired (3)

inactivated influenza vaccine (2 trials)

ot-551 (3 trials)

ot-730 (1 trial)

timolol (blocadren) (1 trial)

Drugs in Phase 1 Trials (1)

jvrs-100 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 5